TRIO PHARMA ApS: Financial statements 2017
CVR: 36499281
Source: annual report 2017, Danish Business Authority
01/05/2016 – 30/04/2017
TRIO PHARMA ApS (CVR 36499281) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -122,663 and a net result of DKK -244,148. Equity in the 2017 report amounted to DKK -246,031.
- Gross Profit
- DKK -122,663
- Profit/Loss
- DKK -244,148
- Equity
- DKK -246,031
- Total Assets
- DKK 467,702
Official annual report
Keep an eye on TRIO PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of January 19, 2017, REVISIONSFIRMAET WOIREMOSE & PARTNER REGISTRERET REVISIONSANPARTSSELSKAB has been appointed auditor of TRIO PHARMA ApS.
About TRIO PHARMA ApS
TRIO PHARMA ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2015. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christian Bo Ratje. The board consists of Michael John Ratje (chair), Christian Bo Ratje and Kirstine Laura Ratje-Johansen. The company is owned by STINE RATJE HOLDING ApS and CHRISTIAN RATJE HOLDING ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK -411,555 and a net result of DKK -1,170,880 compared with DKK -489,664 the year before. Equity in the 2025 report amounted to DKK -2,593,533.